Jan 30 (Reuters) - Guangdong Hybribio Biotech Co Ltd :
* Says its unit plans to inject capital of 14 million yuan into a Wuhan-based life technologies firm, and will own 21.87 percent stake after transaction
Source text in Chinese: goo.gl/hwSFZS
Further company coverage: (Beijing Headline News)
 